Clinical trial
COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases
NCT05236491
Study timeline
Study start (actual)2022-03-09Date precision: day
Registry last updated2023-01-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Rheumatoid Arthritisunresolved
Autoimmune Rheumatologic Diseaseunresolved
Systemic Lupus Erythematosusunresolved
Systemic Vasculitisunresolved
Systemic Sclerosisunresolved
Sclerodermaunresolved
Overlap Connective Tissue Diseaseunresolved
Immunosuppressionunresolved
Interventions
COVID-19 vaccineBIOLOGICAL
Sponsors & collaborators
Paul R Fortinlead sponsor
Canadian Institutes of Health Research (CIHR)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05236491 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.